Reuters logo
BRIEF-EQL Pharma: EMA recommends temporary suspension of EQL Pharma drugs
March 29, 2017 / 2:00 PM / in 8 months

BRIEF-EQL Pharma: EMA recommends temporary suspension of EQL Pharma drugs

March 29 (Reuters) - EQL PHARMA AB:

* SAID ON TUESDAY, THE EUROPEAN MEDICINES AGENCY, EMA, RECOMMENDS TEMPORARY SUSPENSION OF EQL PHARMA DRUGS, WITH REDUCED EARNINGS FOR 2017 AS A RESULT

* LOSS OF INCOME FOR 2017 IS ESTIMATED TO BE 3-4 MILLION SWEDISH CROWNS, WHICH IS EXPECTED TO WORSEN THE RESULT BY AROUND 2 MILLION CROWNS

Source text: bit.ly/2mPsDnW

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below